Clinical trial Recruiting at 1 site Interventional Ages 14 and up

Outpatient care after emergency surgery for gangrenous appendicitis

Official title: Safety, Efficacy, and Cost-effectiveness of Outpatient Surgery for Gangrenous Acute Appendicitis: The PENDI-CSI II Randomized Clinical Trial.

Run by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · NCT07521969 · Data updated 2026-11-12

This trial will test whether people older than 14 with gangrenous appendicitis can be safely discharged home the same day after emergency appendectomy instead of staying in the hospital.

More Appendicitis Acute trials

Quick facts

Study typeInterventional
Ages14 Years and up
SexAll
Enrollment122 (estimated)
SponsorFundación Pública Andaluza para la gestión de la Investigación en Sevilla
Academic / other
Locations1 site (Seville, Sevilla)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedSeptember 1, 2027
Study endsNovember 1, 2027
Registry record updatedApril 21, 2026
Trial IDNCT07521969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients over 14 with intra-operative confirmation of gangrenous appendicitis who tolerate oral intake, have no purulent/fecaloid peritonitis or abscess, do not require abdominal drains, are not immunosuppressed or pregnant, and have family support and ability to attend follow-up.

Probably not a fit

Patients with generalized purulent or faecaloid peritonitis, appendicular abscess, need for drainage, paralytic ileus, ASA IV or selected ASA III status, immunosuppression, active cancer, pregnancy, lack of family support, or inability to comply with follow-up are unlikely to benefit from outpatient discharge.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial at Hospital Universitario Virgen del Rocío compares same-day outpatient discharge to standard inpatient hospitalization for patients with intra-operatively confirmed gangrenous appendicitis. Eligible participants are adolescents and adults over 14 who meet criteria for outpatient discharge and can give informed consent, while patients with generalized purulent or faecaloid peritonitis, abscess, need for drains, immunosuppression, pregnancy, or inability to follow up are excluded. Outcomes include safety measures (postoperative complications and readmissions), recovery markers (oral tolerance, return to activities), and efficiency metrics (length of stay and resource use) over a defined postoperative follow-up period. Randomization occurs after emergency appendectomy once gangrenous appendicitis is confirmed during surgery.

Why it matters

Potential benefit: If successful, the approach could shorten hospital stays, reduce healthcare costs, and allow suitable patients to recover at home sooner.

How similar studies have gone: Same-day discharge after uncomplicated appendectomy has been shown to be safe in other studies, but outpatient management specifically for gangrenous appendicitis has been less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Acute gangrenous appendicitis confirmed during surgery.
* Patient who meets the criteria to be discharged on an outpatient basis
* Signature of informed consent.
* Older than 14 years of age

Exclusion Criteria:

* \- Uncomplicated appendectomy.
* Intra-operative purulent or faecaloid peritonitis
* Appendicular abscess or plastron diagnosed by imaging.
* Paralytic ileus preventing oral tolerance.
* Need for placement of abdominal drainage.
* ASA IV and some selected ASA III.
* Immunosuppression.
* Patients with active neoplasia.
* Pregnancy.
* Doubts in the definitive diagnosis.
* Suspicion of inflammatory bowel disease.
* No family support.
* Failure to sign the informed consent form.
* Impossibility to comply with the follow-up.

Where it's running

  • Hospital Universitario Virgen del Rocío
    Seville, Sevilla, Spain
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.